 | | | | China has pledged to stem a flood of the synthetic opioid fentanyl onto America's streets, where it kills thousands of people a month, but U.S. security experts are skeptical about whether Beijing is willing, or even able, to follow through. | | | | | | Singapore has reported its first case of the rare monkeypox virus brought in by a Nigerian man who authorities said may have been infected by bushmeat he ate at a wedding. | | | | | | Alabama's state Senate on Thursday delayed until next week a vote on the strictest abortion bill in the United States after disagreement arose on the Senate floor about whether to allow women impregnated by rape and incest to have a legal abortion. | | | | | | (Reuters Health) - Almost three in four U.S. allergy specialists are prescribing tablets to ease symptoms caused by pollen, ragweed and dust at least some of the time, though they have not completely shifted away from allergy shots, a survey suggests. | | | | | | (Reuters Health) - In states where pharmacists were allowed to sell the potentially lifesaving opioid antidote naloxone without a prescription, fewer people died from opioid overdoses, a new U.S. study finds. | | | | | | (Reuters Health) - People looking to a popular online symptom checker for answers about eye problems often get a wrong diagnosis, a small study suggests. | | | | | | (Reuters Health) - Many patients with gallstones and abdominal pain don't feel better after a procedure to remove their gallbladder, and a recent study suggests this surgery may not always be necessary. | | | | | | U.S. President Donald Trump called on Congress on Thursday to pass legislation to protect patients from surprise medical bills from out-of-network doctors that can unnecessarily cost patients tens of thousands of dollars. | | | | | | U.S. President Donald Trump slammed the pharmaceutical industry for high prices of prescription drugs on Thursday and vowed to allow U.S. states to buy medicines from other countries if they cost less. | | | | | | Podimetrics, the maker of a smart foot mat that detects warning signs of diabetic foot ulcers, said on Thursday it raised $13.4 million in a funding round led by a group of investors, including venture capital firm Scientific Health Development. | | | | | | Bristol-Myers Squibb Co said on Thursday its immunotherapy Opdivo failed to meet the main goal of a late-stage trial testing it in patients with an aggressive form of tumor that affects the brain or the spine. | | | | | |
